Navigation Links
Hyaluronic Acid Knee Procedures Grow 38% from Q3 2006 to Q3 2007
Date:11/26/2007

Orthopedic Surgeons and Rheumatologists Performing More Procedures

WALTHAM, Mass., Nov. 26 /PRNewswire/ -- Millennium Research Group's US Hyaluronic Acid (HA) Viscosupplementation Marketrack(TM) service, which captures data from both orthopedic surgeons and rheumatologists, shows that both groups provided more HA knee injections in Q3 2007 compared to Q3 2006. While treatments are growing in both groups, there are substantial differences in the products they use in these procedures.

In the survey sample, from Q3 2006 to Q3 2007, average quarterly orthopedic surgeon HA knee injection volumes jumped from 62 to nearly 85. Similarly, over the same time period, average quarterly HA knee injections for rheumatologists increased from 54 to over 75. Fueling this growth is the growing aging population, which is expanding the potential patient pool for HA viscosupplementation each year. In addition, expanding patient awareness of the benefits of HA viscosupplementation injections is also increasing the number of patients seeking and ultimately receiving treatment.

"While both groups' injection numbers are rising, they are using different products," says Kevin Flewwelling, Senior Analyst at MRG. "It turns out that in Q307, orthopedic surgeons mostly used Genzyme's Synvisc, which represented nearly 39% of the total injections administered by orthopedic surgeons. Rheumatologists, on the other hand, tended to use sanofi aventis' Hyalgan most often, which accounted for almost 36% of the total injections administered by this group."

When both groups were asked to rank the most important reasons for prescribing HA viscosupplementation, orthopedic surgeons ranked product efficacy as their number one reason, while rheumatologists reported long-term pain relief as their first priority.

About Hyaluronic Acid Viscosupplementation Marketrack(TM)

HA Viscosupplementation Marketrack(TM) gathers data from 260 orthopedic surgeons, rheumatologists, and other practitioners performing HA Viscosupplementation procedures throughout the US. Data is collected on a quarterly basis. Marketrack subscribers receive thousands of data points, including usage (units, average selling price, and revenue), procedure volumes, distribution channels, competitors, and brand information (Hyalgan, Euflexxa, Orthovisc, Supartz, Synvisc, and others). The project also covers information on the competing corticosteroid markets.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
2. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
(Date:2/3/2016)... Ascendis Pharma A/S (Nasdaq: ASND ), ... TransCon technology to address significant unmet medical needs, today ... Leerink Partners Global Healthcare Conference Location: , Waldorf ... 2016 Time:  , 11:55am EST www.ascendispharma.com ... An audio webcast of this event will be posted ...
(Date:2/3/2016)... , Feb. 3, 2016 New ... more than $1 million for researchers in ... on health-related research that demonstrates exciting potential.   ... of funding for the New Jersey Health Foundation Research ... members at these educational institutions— Princeton University, Rutgers ...
(Date:2/3/2016)... ... 2016 , ... ProMIS Neurosciences is currently in the process ... propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company plans to ... on from the first misfolded Amyloid beta target announced on Nov. 12, 2015, ...
Breaking Biology Technology:
(Date:1/11/2016)... CHICAGO , Jan. 11, 2016  higi, ... via nearly 10,000 retail locations, web and mobile, ... than $40 million from existing investors. ... will be devoted to further innovate higi,s health ... app and web portal – including expanding services ...
(Date:1/7/2016)... -- This BCC Research report studies the global as ... identifying newer markets and exploring the expansion of the ... Includes forecast from 2015 to 2020. Use ... the expansion of the present application market for various ... technology, determine its current market size, and estimate the ...
(Date:1/6/2016)... 2016  Varam Capital, a provider of micro-finance inclusion ... deliver advanced authentication solutions to their clients. Varam supplies ... A loan of a few thousand rupees may make ... ability to purchase livestock or equipment for a small ... for a local store. ...
Breaking Biology News(10 mins):